Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial.
Pontes-García A, Martínez-López A, Rodríguez-Ortiz L, Valenzuela-Molina F, Rufián-Andújar B, Sánchez-Hidalgo JM, Casado-Adam A, Gordon-Suarez A, Rufián-Peña S, Vázquez-Borrego MC, Romero-Ruiz A, Arjona-Sánchez A.
Pontes-García A, et al. Among authors: casado adam a.
Eur J Surg Oncol. 2023 Sep;49(9):106978. doi: 10.1016/j.ejso.2023.07.004. Epub 2023 Jul 11.
Eur J Surg Oncol. 2023.
PMID: 37460370
Clinical Trial.